Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Rubio

Showing results (161-170 of 268) with videos related to

Pageof 27
Sort By:
Cardiology Journal|May 22, 2025
Baseline left ventricular ejection fraction predicts the magnitude of improvement in patients taking sacubitril/valsartanJosé-Manuel Rubio-Campal, Carlos Rodriguez Lopez, Carla Lázaro Rivera, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 9, 2022
Miniseries 2-Septal and paraseptal accessory pathways-Part III: Mid-paraseptal accessory pathways-revisiting bypass tracts crossing the pyramidal spaceJerónimo Farré, Robert H Anderson, José-Manuel Rubio, et al.
Journal of the American Geriatrics Society|February 19, 2016
Comparison of Implantable Cardioverter Defibrillator Therapy and Medical Therapy in Individuals Aged 75 and OlderMarcelino Cortés, Julia Anna Palfy, Jerónimo Farré, et al.
Molecular and Cellular Biology|August 8, 2007
Drp1 mediates caspase-independent type III cell death in normal and leukemic cellsMarlène Bras, Victor J Yuste, Gaël Roué, et al.
Antiviral Therapy|September 13, 2005
Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patientsEsteban Ribera, Dolors Rodríguez-Pardo, Manuel Rubio, et al.
Leukemia & Lymphoma|December 11, 2007
Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825)Ricardo García-Muñoz, Alicia Galar, Cristina Moreno, et al.
Plos One|August 8, 2012
CD47(low) status on CD4 effectors is necessary for the contraction/resolution of the immune response in humans and miceVu Quang Van, Nobuyasu Baba, Manuel Rubio, et al.
Medicine|July 21, 2017
Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, SpainJuan Mañá, Manuel Rubio-Rivas, Nadia Villalba, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 9, 2022
Miniseries 2-Septal and paraseptal accessory pathways-Part II: Para-Hisian accessory pathways-so-called anteroseptal pathways revisitedJerónimo Farré, Robert H Anderson, Damián Sánchez-Quintana, et al.
The Journal of Infection|February 14, 2021
Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter studyJaime Lora-Tamayo, Guillermo Maestro, Antonio Lalueza, et al.
Pageof 27

Showing results (161-170 of 268) with videos related to

Sort By:
Pageof 27
Cardiology Journal|May 22, 2025
Baseline left ventricular ejection fraction predicts the magnitude of improvement in patients taking sacubitril/valsartanJosé-Manuel Rubio-Campal, Carlos Rodriguez Lopez, Carla Lázaro Rivera, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 9, 2022
Miniseries 2-Septal and paraseptal accessory pathways-Part III: Mid-paraseptal accessory pathways-revisiting bypass tracts crossing the pyramidal spaceJerónimo Farré, Robert H Anderson, José-Manuel Rubio, et al.
Journal of the American Geriatrics Society|February 19, 2016
Comparison of Implantable Cardioverter Defibrillator Therapy and Medical Therapy in Individuals Aged 75 and OlderMarcelino Cortés, Julia Anna Palfy, Jerónimo Farré, et al.
Molecular and Cellular Biology|August 8, 2007
Drp1 mediates caspase-independent type III cell death in normal and leukemic cellsMarlène Bras, Victor J Yuste, Gaël Roué, et al.
Antiviral Therapy|September 13, 2005
Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patientsEsteban Ribera, Dolors Rodríguez-Pardo, Manuel Rubio, et al.
Leukemia & Lymphoma|December 11, 2007
Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825)Ricardo García-Muñoz, Alicia Galar, Cristina Moreno, et al.
Plos One|August 8, 2012
CD47(low) status on CD4 effectors is necessary for the contraction/resolution of the immune response in humans and miceVu Quang Van, Nobuyasu Baba, Manuel Rubio, et al.
Medicine|July 21, 2017
Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, SpainJuan Mañá, Manuel Rubio-Rivas, Nadia Villalba, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 9, 2022
Miniseries 2-Septal and paraseptal accessory pathways-Part II: Para-Hisian accessory pathways-so-called anteroseptal pathways revisitedJerónimo Farré, Robert H Anderson, Damián Sánchez-Quintana, et al.
The Journal of Infection|February 14, 2021
Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter studyJaime Lora-Tamayo, Guillermo Maestro, Antonio Lalueza, et al.
Pageof 27